Jeanne Erdmann is an award-winning health and science writer based in Wentzville, Mo. A member of Association of
Health Care Journalists board of directors, she is the chair of the organization’s Freelance Committee. Her work has appeared in Discover, Women’s Health, Aeon, Slate, The Washington Post, Nature, Nature Medicine and other publications. You can follow her at @jeanne_erdmann.
Jeanne Erdmann
From this contributor
Analysis pins down prevalence of mental health conditions in autism
Eight mental health conditions occur unusually often in autistic people, a new analysis suggests.
Analysis pins down prevalence of mental health conditions in autism
By
Jeanne Erdmann
7 October 2019 | 2 min read
Drug screen reveals potential treatments for Rett syndrome
An experimental leukemia drug and a chemical in black pepper ease breathing and movement problems in a mouse model of Rett syndrome.
Drug screen reveals potential treatments for Rett syndrome
By
Jeanne Erdmann
11 September 2019 | 4 min read
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
By
Helena Kudiabor
15 April 2026 | 4 min read